The cagrilintide component addresses appetite and satiety through amylin signaling, while retatrutide simultaneously optimizes glucose metabolism, energy expenditure, and fat oxidation through its triple mechanism
It's not proven if these agents work well, and they are unlikely to have much benefit
So the goal of the B12 component is correction and prevention: keeping levels from dropping during treatment, which can in turn help offset the fatigue, brain fog, and irritability that may otherwise show up around weeks 4 to 8 of GLP-1 treatment
No anti-AOD9604 antibodies detected
BPC-157 Best for: soft-tissue, tendon, and gut-lining recovery in preclinical research BPC-157 is a synthetic pentadecapeptide, a 15-amino-acid chain (sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), derived from a protective protein naturally found in human gastric juice